Almitas Capital LLC Alector, Inc. Transaction History
Almitas Capital LLC
- $177 Million
- Q1 2025
A detailed history of Almitas Capital LLC transactions in Alector, Inc. stock. As of the latest transaction made, Almitas Capital LLC holds 321,568 shares of ALEC stock, worth $463,057. This represents 0.22% of its overall portfolio holdings.
Number of Shares
321,568
Previous 284,845
12.89%
Holding current value
$463,057
Previous $538,000
26.58%
% of portfolio
0.22%
Previous 0.26%
Shares
2 transactions
Others Institutions Holding ALEC
# of Institutions
148Shares Held
55.5MCall Options Held
56.4KPut Options Held
23.2K-
Ra Capital Management, L.P. Boston, MA9.7MShares$14 Million0.25% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$13.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.05MShares$8.72 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$2.83 Million0.0% of portfolio
-
State Street Corp Boston, MA1.64MShares$2.36 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $119M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...